Designing Longevity
Skip to main content
Brand-name GLP-1

Ro

A branded-prescription membership with medication coverage navigation.

Edited by Designing Longevity Editorial · earlier profile checked May 1, 2026

Current program terms checked October 13, 2026. This page presentation was updated October 14, 2026. Earlier full-profile and public-record dates are shown separately below.

Current published program

Ro at a glance

Ro is worth comparing when insurance paperwork is the main friction. It publishes a coverage-support pathway and multiple billing terms; the care fee remains payable even when the drug uses insurance.

Program sources checked October 13, 2026. This program review covers shopping features, not clinical or pharmacy quality.

See published program terms and sources

Care costs, billing and advertised support for this program

Visit Ro $149 / month care fee; medication billed separately.

No financial relationship with Ro; editorial inclusion only. How we get paid

Ro logo
Care fee
$149 / month

Care fee only; medication is extra. Monthly care billing.

Medication cost
Separate from care

This care fee is not a total treatment price. Ask for the prescribed medication and pharmacy charge in writing.

Insurance route
Drug insurance help

Coverage support for selected branded medicines; membership remains an extra charge.

Billing and cancellation
Monthly care billing

Cancel at least 48 hours before renewal.

What is published

  • Insurance concierge
  • Published billing options
  • On-demand messaging

What to confirm

  • Care fee is extra
  • Medication is extra
  • Lower equivalent rates require prepayment

Care format: On-demand provider messaging and ongoing support advertised; fixed live visit cadence not established. Coaching advertised; registered-dietitian appointments not established.

Prescription limits: Prescription and availability depend on clinician assessment, product, state and plan. Pharmacy route depends on the medication and payment option.

Program questions and source links

What does Ro's care program cost?

$149 / month is the published care charge. Care fee only; medication is extra. Medication is billed separately. Billing: Monthly care billing.

Can I use insurance with Ro?

Coverage support for selected branded medicines; membership remains an extra charge. Ask for a written care and medication quote before enrolling.

How do I cancel Ro?

Cancel at least 48 hours before renewal.

What does the program-terms checklist cover?

It records sourced, dated care costs, billing rules and advertised support for this named program. It does not assess medical quality, safety, treatment outcomes or patient satisfaction. Incomplete or expired evidence calls for a new source check.

Official sources and checked dates

Reviews of individual programs

Program reviews cover their own costs, terms and support. The program-terms checklist applies to the named care program, not every service offered by this company.

Ro GLP-1 program review

Program costs and payment terms

Public program terms checked November 6, 2026. Public pricing, insurance support, oral Wegovy availability and subscription terms only; clinical care and credentials were not rechecked.

Membership
$39 first month, then $149/month; medication extra.
Insurance
Support is listed for selected branded injections. Coverage and medication out-of-pocket cost require a plan-specific quote; membership is extra.
Oral Wegovy
Listed; eligibility and prescription required.
Membership prepayment
Prepaid membership equivalents: $99/month for 3 months ($297 upfront), $89/month for 6 months ($534 upfront), $74/month for 12 months ($888 upfront). Medication is extra. Confirm how any introductory offer applies, the amount charged now, the recurring amount and the next renewal date before paying.
Cancel before renewal
Cancel at least 48 hours before renewal.
Intro offer and refunds
The introductory membership payment is refunded if ineligible; paid ongoing membership fees are non-refundable.
Stopping medication
Membership continues unless canceled, even without medication.
Outside pharmacy orders
LillyDirect product refunds, replacements and disputes follow the dispensing pharmacy policies.

Designing Longevity is a founder-led editorial publication. Our content is not medically reviewed.

The full profile and rubric were last checked May 1, 2026. Current commercial terms above have their own check date; they do not refresh earlier ratings or clinical claims.

Read the earlier full profile and source record (May 1, 2026)

This record keeps its original check dates. The program-terms checklist above covers costs, billing and advertised support for the named care program.

Earlier editorial take

Earlier review: best for

  • Patients who want one platform for multiple verticals

    Ro covers weight loss, men's health, hair loss, fertility, and skincare. If you'd rather use one provider for several needs, Ro is the most credible multi-vertical option.

  • Users who value mature support infrastructure

    Largest user base in the cohort and longest tenure means the operation is well-rehearsed.

Our take

The full profile retains its earlier verification date. Check the dated program terms below before choosing.

Pros

  • Both brand-name (, , ) and options
  • Established platform with mature support and largest user base in cohort
  • Accredited since 2018 (B rating)
  • review volume (21,800+) is the largest signal in our cohort and skews positive (4.4/5)

Cons

  • April 2025 FDA finasteride alert reflects on Ro's compounder-vendor track record
  • sourcing less transparent than vertically-integrated competitors

Pricing

$39 first month, then $149/month; medication extra.

Turnaround

Same-day Rx after async intake

States served

All 50

Earlier full review checked

May 1, 2026

Earlier rubric breakdown

How the earlier rating was scored

Licensure

20% weight
4.0/5

License and enforcement records checked at the profile verification date.

Active multi-state licensure across 50 states; no specifically on Ro at capture date. Counterweight: April 2025 FDA safety alert on topical finasteride explicitly applies to compounders and telemedicine platforms, and Ro markets compounded topical finasteride, so the alert reflects on the company even though Ro wasn't named.

Evidence checked in the earlier review (4)

  • Roman Health Ventures, Inc. (operating entity)

    Business filing

    Long-established corporate parent; founded 2017 as Roman, rebranded to Ro.

    Checked May 1, 2026

  • No FDA warning letter on Ro / Roman Health Ventures

    Federal database

    Verified against the FDA warning-letter database at capture date. None on record.

    Checked May 1, 2026 · source

  • April 2025 FDA safety alert on compounded topical finasteride (industry-wide)

    Federal alert

    FDA alert dated April 25, 2025 cites adverse events including suicidal ideation, depression, and erectile dysfunction tied to topical finasteride. Ro markets compounded topical finasteride for hair loss, so the alert reflects on the company even though Ro is not named.

    Checked May 1, 2026 · source

  • Active multi-state licensure

    State licensure

    Ro operates across all 50 states via licensed clinicians in each jurisdiction.

    Checked May 1, 2026

Accreditation

20% weight
4.0/5

Accreditation records checked at the profile verification date.

Accredited since July 23, 2018 with a B rating, among the longest-tenured BBB-accredited telehealth platforms. not independently confirmed on a public-registry URL at capture date (LegitScript doesn't publish a per-merchant directory); Ro advertises on Google and Meta, which generally requires LegitScript certification, so it's a strong inference.

Evidence checked in the earlier review (3)

  • BBB Accredited Business since July 23, 2018

    Accreditation

    Current rating: B. Long-tenured accreditation is itself a positive signal.

    Checked May 1, 2026 · source

  • LegitScript Healthcare Merchant Certification

    Accreditation

    Inferred from Ro's active Google and Meta advertising (which requires ), but LegitScript does not publish a public per-merchant directory URL we could confirm against.

    Checked May 1, 2026 · source

  • PCAB on partner compounding pharmacies

    Partner accreditation

    Ro uses partner compounding pharmacies for ; specific partner accreditations not publicly disclosed at fill level.

    Checked May 1, 2026

Transparency

20% weight
3.5/5

Published testing, sourcing, and formulation information.

sourcing details (which or partner) less granular than vertically-integrated competitors like Eden.

Evidence checked in the earlier review (2)

  • Compounded source pharmacy named per fill

    Sourcing

    Ro uses a network of compounding partners; specific partner per fill is not surfaced publicly.

    Checked May 1, 2026

  • "Compounded medications are not FDA-approved" disclosure published

    Compliance disclosure

    Checked May 1, 2026

Product quality

15% weight
3.5/5

Published testing, recall, and supply-chain information.

This earlier product-quality score has not been refreshed. The commercial update does not recheck manufacturing, sourcing or clinical care.

Evidence checked in the earlier review (4)

  • No FDA recalls on Ro-distributed GLP-1 product

    Recall history

    Checked May 1, 2026 · source

  • Branded GLP-1 supply via authorized distribution

    Sourcing

    , , and dispensed through standard pharmaceutical supply chain.

    Checked May 1, 2026

  • Compounded GLP-1 third-party lot testing program

    Testing

    Specific testing programs at partner pharmacies not publicly detailed at the per-fill level.

    Checked May 1, 2026

  • Compounder-vendor management (cross-product line)

    Vendor oversight

    April 2025 FDA finasteride alert applies to compounders and telemedicine platforms; Ro's topical finasteride line is in scope. Indicates a compounder-vendor track record that warrants scrutiny across product lines.

    Checked May 1, 2026 · source

Pricing

15% weight
3.0/5

Value within the category, no surprise fees, refund policy.

$39 first month, then $149/month; medication extra.

Customer service

10% weight
3.5/5

Refund policy, support quality, complaint history.

Wide review-platform split: 3.7/5 across ~3,200, B rating accredited since 2018, 4.4/5 across ~21,800. The ConsumerAffairs volume is significant (far larger sample than Trustpilot) and skews more positive.

Evidence checked in the earlier review (3)

  • Trustpilot rating: 3.7/5 across 3,198 reviews

    External review

    Checked May 1, 2026 · source

  • ConsumerAffairs rating: 4.4/5 across 21,848 reviews

    External review

    Largest external review sample in our cohort; meaningfully more positive than .

    Checked May 1, 2026 · source

  • Adverse-event reporting path documented

    Safety

    Checked May 1, 2026

Public reviews

What we found across third-party review platforms. These are external sentiment signals, not our scoring inputs.

Trustpilot

3.7 stars across 3,198 reviews, "Average" per 's banding. Strongest themes: convenience, ease of use, professional support. Negatives concentrate on cancellation friction and surprise charges.

Captured May 1, 2026Source

Better Business Bureau

Accredited since July 23, 2018; current rating B. Telemedicine business in New York, NY. Complaint patterns: misleading headline pricing (membership vs medication), unexpected charges, refund difficulties on cancellation.

Captured May 1, 2026Source

ConsumerAffairs

Markedly more positive than or : 4.4/5 across 21,848 reviews. Largest review sample in our cohort by an order of magnitude. The split between platforms is wide enough to weigh both: volume is meaningful, BBB pattern is also meaningful.

Captured May 1, 2026Source

Regulatory & legal history

FDA enforcement actions, manufacturer lawsuits, recalls, and other notable events on the public record.

  1. FDA Warning LetterApril 25, 2025

    FDA safety alert on topical finasteride products cites 32 reports of adverse events between 2019-2024, including suicidal ideation, anxiety, depression, erectile dysfunction, and persistent symptoms after discontinuation. The alert applies to compounders and telemedicine platforms; Ro markets compounded topical finasteride for hair loss and is in scope even though not named in the alert.

    Source

What to expect

  1. 1

    Pharmacy fulfillment

    3-7 days

    Approved routes to either an in-network pharmacy (branded) or a partner compounding pharmacy (). Cold-chain shipping handled by the fulfilling pharmacy.

Accreditations

State pharmacy/clinic license

Verified · May 1, 2026

LegitScript Certified

Unverified · May 1, 2026 · source

Frequently asked

What does Ro charge for membership?

$39 first month, then $149/month; medication extra.

Does Ro accept insurance?

Support is listed for selected branded injections. Coverage and medication out-of-pocket cost require a plan-specific quote; membership is extra.

Is Ro the same as Roman?

Yes. Ro was founded in 2017 as Roman, focused on men's health (ED, hair loss). The company rebranded to Ro and expanded into multiple verticals including weight loss (Ro Body), women's health, fertility, and dermatology. Operating entity is Roman Health Ventures, Inc., based in New York.

Is Ro BBB-accredited?

Yes. Ro has been Accredited since July 23, 2018 with a current rating of B. The profile is at https://www.bbb.org/us/ny/new-york/profile/telemedicine/ro-0121-173581 if you want to read complaints directly. Long-tenured BBB accreditation is itself a positive signal.

Why is Ro flagged for the FDA finasteride alert?

On April 25, 2025, the FDA issued a safety alert about topical finasteride products, citing 32 reports of adverse events including suicidal ideation, anxiety, and persistent symptoms after discontinuation. The alert explicitly applies to compounders and telemedicine platforms. The FDA didn't name Ro specifically, but Ro markets compounded topical finasteride for hair loss, so the alert reflects on the company's compounder-vendor management even though it's a different product line from .

Update history

Every meaningful change to this profile, with a date stamp. We don't silently re-score.

  1. May 1, 2026

    Initial published profile. Sources HEAD-checked at publish time. Score reflects honest math after surfacing the April 2025 FDA finasteride alert (industry-wide but applies to Ro's product mix), the complaint pattern around membership-vs-medication billing transparency, and the wide review-platform split ( 3.7 vs 4.4 vs BBB B). Insurance concierge for branded remains the genuine differentiator.

Edited by Designing Longevity Editorial. Earlier profile checked May 1, 2026.

Spot something out of date or wrong? Let us know and we'll re-check.

Back to all providers